Form 4: Nuvalent Executive Sells Shares Under 10b5-1 Plan

Nuvalent's Chief Development Officer, Darlene Noci, executed a Rule 10b5-1 trading plan, resulting in the sale of Nuvalent Inc. Class A Common Stock.

Summary

• Darlene Noci, Chief Development Officer at Nuvalent, Inc., engaged in transactions involving Class A Common Stock on July 1, 2026.
• These transactions were conducted under a pre-established Rule 10b5-1 trading plan adopted on November 18, 2024.
• Noci acquired 9,146 shares at $18.93 and 13,854 shares at $72.35, both under stock options.
• Additionally, 23,000 shares were disposed of at a weighted average price of $123.59, with individual sales ranging from $123.51 to $123.62.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a slightly negative filing due to the significant sale of shares by a key executive, despite being executed under a pre-planned 10b5-1 trading plan.

Positives

• The transactions were executed under a Rule 10b5-1 plan, indicating pre-planned and potentially non-insider trading activity.
• Some stock options were exercised, suggesting the reporting person is utilizing previously granted equity compensation.
• The reporting person continues to hold a significant number of shares (58,117) after the reported transactions.

Negatives

• A substantial number of shares (23,000) were sold, which could be interpreted as a lack of confidence in near-term stock appreciation by a key executive.
• The sale of shares at a price significantly higher than the exercise price of the options ($123.59 vs. $18.93 and $72.35) represents a realization of profit by the executive.

Risks

• The sale of a significant number of shares by a key executive could be perceived negatively by the market, potentially impacting investor sentiment.
• While executed under a 10b5-1 plan, large sales by insiders can still lead to downward pressure on the stock price.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions.

Management Comments

• The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2024.
• The price reported for the sale of 23,000 shares is a weighted average price, with actual sales occurring at prices ranging from $123.51 to $123.62.
• The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request.

Industry Context

StockSavvy.ai notes that insider selling, even under a 10b5-1 plan, is a common event for executives to diversify holdings or manage personal finances. However, the volume and timing relative to stock performance can influence market perception.

Stakeholder Impact

• Shareholders may view the sale of a significant number of shares by a key executive with concern, potentially leading to short-term negative sentiment towards the stock.
• Employees holding stock options may be influenced by the executive's decision to sell shares, though the 10b5-1 plan mitigates concerns about insider trading.

Key Dates

Recommendation

The filing reports routine insider transactions under a 10b5-1 plan, which are generally not indicative of a fundamental change in the company's prospects. While the sale of shares by an executive can create short-term negative sentiment, the continued holding of a substantial number of shares and the pre-planned nature of the sale suggest a neutral stance is appropriate for seasoned investors.

Keywords

Nuvalent, NUVL, Form 4, Insider Trading, Rule 10b5-1, Stock Options, Share Sale, Executive Compensation, Beneficial Ownership